UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES
© 2026 Newsquawk. All rights reserved.